Robin Wyn is currently a Technical Lead at Adelphi Values, where they focus on outcomes research and systematic reviews, particularly in health state utility across various therapy areas, including oncology, immunology, neurology, respiratory health, and diabetes. They previously held the title of Senior Technical Value Analyst at the same company from 2018 to 2019. Robin earned a Master’s Degree in Biotechnology from The University of Salford in 2014 and a Bachelor’s Degree in Biology (with Honours) from The University of Manchester in 2013.
This person is not in the org chart
This person is not in any offices